Shares of Sun Pharma Advanced Research Company (SPARC), a unit of India’s largest drug maker Sun Pharmaceuticals Ltd. fell as much as 18% on Wednesday, June 4, after it announced results from its Phase 2 trials of the SCD-044 drug.The SCD-044 or Vibo…
SPARC shares fall 18% after Sun Pharma’s key psoriasis drug fails to get desired outcome
